EUCTR2007-007460-22-DE进行中（未招募）不适用
International Survival Follow-up of Patients Enrolled In the Renal Cell Carcinoma Evaluation of Adjuvant Oncophage® Treatment in the Antigenics C-100-12 (Part I) Protocol.(INSPIRE) - INSPIRE
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 436
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •To be eligible, patients must have
- •1. Participated in the Antigenics C-100-12 (part I) protocol, and terminated the study with last survival status reported as 'alive' and due to 'administrative study closure'
- •2. Signed an informed consent to participate in the C-100-27 Survival Follow-up protocol, and be willing to receive contact from a representative from the protocol investigative study centers and/or any subsequently identified co-investigator sites where patients consent to continued survival follow-up and/or a member from a company designated by the Sponsor every 6 months if no disease recurrence and every 3 months if disease has recurred.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
International Survival Follow-up of Patients Enrolled In the Renal Cell Carcinoma Evaluation of Adjuvant Oncophage® Treatment in the Antigenics C-100-12 (Part I) Protocol.(INSPIRE) - INSPIRERenal Cell CarcinomaMedDRA version: 9.1Level: LLTClassification code 10038395Term: Renal carcinomaEUCTR2007-007460-22-ATAntigenics Inc.436
进行中（未招募）
不适用
International Survival Follow-up of Patients Enrolled In the Renal Cell Carcinoma Evaluation of Adjuvant Oncophage® Treatment in the Antigenics C-100-12 (Part I) Protocol (INSPIRE). - INSPIREEUCTR2007-007460-22-SEAntigenics Inc.436
已完成
不适用
International long-term follow-up study of patients implanted with a PORTICO* valveAorta Stenosis - aorta valve calcification10046973NL-OMON43837St. Jude Medical30
进行中（未招募）
1 期
Global Registry for Long-Term Follow-up of Patients Participating in Clinical Trials with Posoleucel (ALVR105)Adenovirus (AdV), BK virus (BKV), John Cunningham virus (JCV), human herpesvirus 6 (HHV- 6), Epstein-Barr virus (EBV), and cytomegalovirus(CMV) infections and/or disease in patients at high risk for these viruses following allogeneic hematopoietic cell transplant (HCT) or solid organ transplant (SOT).MedDRA version: 21.1Level: PTClassification code 10060931Term: Adenovirus infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.1Level: PTClassification code 10055181Term: BK virus infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 21.1Level: PTClassification code 10023163Term: JC virus infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 22.0Level: PTClassification code 10020431Term: Human herpesvirus 6 infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 21.1Level: PTClassification code 10015108Term: Epstein-Barr virus infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.1Level: PTClassification code 10011831Term: Cytomegalovirus infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2022-000763-45-BEAlloVir, Inc.500
进行中（未招募）
1 期
Global Registry for Long-Term Follow-up of Patients Participating in Clinical Trials with Posoleucel (ALVR105)Adenovirus (AdV), BK virus (BKV), John Cunningham virus (JCV), human herpesvirus 6 (HHV- 6), Epstein-Barr virus (EBV), and cytomegalovirus(CMV) infections and/or disease in patients at high risk for these viruses following allogeneic hematopoietic cell transplant (HCT) or solid organ transplant (SOT).MedDRA version: 21.1Level: PTClassification code 10060931Term: Adenovirus infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.1Level: PTClassification code 10055181Term: BK virus infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 21.1Level: PTClassification code 10023163Term: JC virus infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 22.0Level: PTClassification code 10020431Term: Human herpesvirus 6 infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 21.1Level: PTClassification code 10015108Term: Epstein-Barr virus infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.1Level: PTClassification code 10011831Term: Cytomegalovirus infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2022-000763-45-SEAlloVir, Inc.237